Drug intelligence / Profile preview

Typhoid Vi Polysaccharide vaccine (DAVAC)

Development stage
Approved
Lead developer
Dalat Pasteur Vaccines
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

This is a typhoid Vi polysaccharide vaccine developed and manufactured by Dalat Pasteur Vaccines (DAVAC) in Vietnam. It is a biologic product designed to provide active immunization against typhoid fever caused by *Salmonella enterica* serovar Typhi. The vaccine consists of the purified Vi capsular polysaccharide antigen, which is a major virulence factor of the bacterium. Upon intramuscular administration, the vaccine induces the production of protective antibodies against the Vi antigen, thereby preventing infection. It is approved for use in Vietnam and is part of the national effort to control typhoid fever.

Brand names
VẮC XIN THƯƠNG HÀN Vi Polysaccharide
Other names
Typhoid Vi vaccineVi capsular polysaccharide vaccineDAVAC Typhoid Vi vaccine
02

Targets

Vi antigen (Vi capsular polysaccharide)

Beyond the preview

Go deeper on Typhoid Vi Polysaccharide vaccine (DAVAC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Typhoid Vi Polysaccharide vaccine (DAVAC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call